Global Pharmaceuticals Industry Strategic Research Report

The global pharmaceutical consumption market was valued at approximately $1.55 trillion in calendar year 2024, advancing to an estimated $1.65 trillion in 2025, the report's base year. Over the 2025-2031 forecast window, the market is projected to expand at a compound annual growth rate of 6.8% in nominal US dollar terms, reaching $2.45 trillion by 2031 - an absolute increment of approximately $795 billion of annual consumption value across the period.

This forecast acceleration is material relative to the historical baseline. The 2022-2024 historical CAGR stood at 4.3%, a comparatively subdued rate reflecting post-COVID-19 normalisation of vaccine demand and inventory destocking. The transition to the 6.8% forward trajectory is underpinned by five discrete structural catalysts, the largest being GLP-1 receptor agonist and cardiometabolic franchise expansion (anchored by semaglutide and tirzepatide), estimated to add approximately $280 billion of incremental consumption value by 2031.

Twenty-five companies are profiled in depth, including Johnson & Johnson, Pfizer, Roche, Merck, AbbVie, Novartis, AstraZeneca, Sanofi, Bristol-Myers Squibb, Eli Lilly, GSK, Novo Nordisk, Takeda, Bayer, Boehringer Ingelheim, Amgen, Gilead, Vertex, Regeneron, Biogen, Moderna, Teva, Viatris, Sun Pharma, and Dr. Reddy's Laboratories.

Scope of Global Pharmaceuticals Industry Strategic Research Report 2026-2031

• This report provides forecast data by value (in USD billion) till 2031 for the global pharmaceutical consumption (drug market) industry, with 2025 as the base year and 2022-2024 as the historical period.
• This report provides segment by type (Small Molecule, Biologics, Vaccines, Cell and Gene Therapy, Peptide Therapeutics, Oligonucleotides, and Combination/OTC/Other) forecast data by value for the global pharmaceutical consumption market till 2031.
• This report provides application segments (Oncology, Cardio-Metabolic, Immunology and Inflammation, Infectious Disease, Neurology and CNS, Respiratory, Rare Diseases and Orphan Drugs, and Other Applications) forecast data by value for the global pharmaceutical consumption market till 2031.
• This report provides region-wise (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa) forecast data by value for the global pharmaceutical consumption market till 2031.
• This report also provides country-wise forecast data by value for the United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, Switzerland, Netherlands, Belgium, Turkey, and other major markets across all five regions.
• This report identifies key growth drivers and inhibitors (pain points) affecting the global pharmaceutical consumption market.
• This report provides SWOT (Strengths, Weaknesses, Opportunities and Threats) analysis, company profiles including Company Overview, Key Products & Segments, Financial Performance, Business Strategy, and Strategic Implications, along with competitive landscape for 25 key companies in the global pharmaceutical consumption market.
• This report provides Porter's Five Forces analysis for the global pharmaceutical consumption market.
• This report provides PESTLE (political, economic, social, technological, legal and environmental) analysis for the global pharmaceutical consumption market.
• This report provides SWOT (Strengths, Weaknesses, Opportunities and Threats) analysis for the global pharmaceutical consumption market.
• This report identifies key future trends in the global pharmaceutical consumption market.

Segment by Type in Global Pharmaceuticals Industry Market

• Small Molecule (Chemical)
• Biologics (mAbs, Recombinant Proteins)
• Vaccines
• Cell and Gene Therapy
• Peptide Therapeutics
• Oligonucleotides (siRNA and Antisense Oligonucleotides)
• Combination, OTC and Other

Segment by Application in Global Pharmaceuticals Industry Market

• Oncology
• Cardio-Metabolic (Diabetes, Obesity, and Cardiovascular)
• Immunology and Inflammation
• Infectious Disease (Including Vaccines)
• Neurology and Central Nervous System
• Respiratory
• Rare Diseases and Orphan Drugs
• Other Applications

Segment by Region in Global Pharmaceuticals Industry Market

• North America
  • United States
  • Canada
  • Rest of North America
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Switzerland
  • Netherlands
  • Belgium
  • Turkey
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • United Arab Emirates
  • South Africa
  • Rest of Middle East & Africa

Who can use the Global Pharmaceuticals Industry Market Research Report?

This research report is ideal for people who wish to gain a thorough understanding of the global pharmaceutical consumption market. Some of the intended users for this report are:

• C-level executives and Company Directors in pharmaceutical, biotechnology, and healthcare companies
• Industry consultants and Management consultants
• Marketing professionals and Business development professionals
• Investment managers, Financial professionals, and Venture Capitalists
• Bank Managers, M&A Managers, and Auditors
• Payers, Healthcare Policy Analysts, and Market Access professionals
• Portfolio Managers and Equity Research Analysts covering pharmaceuticals
• Anyone operating in the pharmaceutical industry value chain, from R&D through commercialization